Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2025-12-25 @ 1:40 PM
NCT ID: NCT02461992
Description: None
Frequency Threshold: 0
Time Frame: Baseline up to Day 28
Study: NCT02461992
Study Brief: Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Xyntha 50 IU/kg Participants were administered a single dose of recombinant antihemophilic factor (Xyntha) at 50 international units per kilogram (IU/kg) infused intravenously over 10 minutes. None None 2 13 2 13 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Factor VIII inhibition NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA version 18.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 18.1 View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA version 18.1 View